. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Predictive Biomarkers for Parkinson's Disease

Reference #:

2006-179

Inventors/Contributors

Demetrius (Jim) M. Maraganore M.D., Timothy G. Lesnick

Description

We explored an available whole-genome association dataset to identify single nucleotide polymorphisms within brain-expressed, axon guidance pathway genes that predicted Parkinson’s disease outcomes. We identified models of SNPs that strongly predicted susceptibility (P=4.64 x 10-38), survival free of Parkinson’s disease (P=5.43 x 10-48), and age at onset (P=1.68x10-51). Polymorphism in the axon guidance pathway accounted for nearly 70% of the age at onset variance of Parkinson’s disease, and person with high versus low model scores differed in survival free of Parkinson’s disease by more than 20 years.

Patent Status

Pending

Contact

Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-1222
Fax: (507) 284-5410